Sagent Pharmaceuticals Issues Voluntary Nationwide Recall Of Docetaxel Injection, USP Due To Potential Presence Of Particulate Matter

SCHAUMBURG, Ill., May 28, 2024 /PRNewswire/ -- Sagent Pharmaceuticals today announced the voluntary nationwide recall of two lots of Docetaxel Inject

Related Keywords

,Sagent Pharmaceuticals ,Drug Administration ,Fedex ,Prnewswire Sagent Pharmaceuticals ,Docetaxel Injection ,User Level ,Expiration Dates ,Medical Affairs ,Watch Adverse Event Reporting ,